[Novel CD19-KIRS2/Dap12-BB CAR-T Treatment for 3 Patients with Relapsed and Refractory B-Cell Tumors].
Ji SW, Hua T, Wang JJ, Shao LY, Chen ZH, Liu JY, Cheng H, Chen W, Sun C, Wang X, Xu KL, Cao J.
Ji SW, et al. Among authors: shao ly.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Dec;31(6):1860-1865. doi: 10.19746/j.cnki.issn.1009-2137.2023.06.040.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023.
PMID: 38071073
Chinese.